Nuclear factor-κB essential modulator (NEMO), the regulatory subunit of the IκB kinase (IKK) complex, is a critical component of the NF-κB pathway. Hypomorphic mutations in the X-linked human NEMO gene cause various forms of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). All known X-linked EDA-ID-causing mutations impair NEMO protein expression, folding or both. We describe here two EDA-ID-causing missense mutations affecting the same residue in the CC2-LZ domain, D311N and D311G, which do not impair NEMO production or folding. Structural studies based on pull-down experiments showed a defect in non-covalent interaction with K63-linked and linear polyubiquitin chains (Poly-ub) for these mutant proteins. Functional studies on the patients'cells showed an impairment of the classical NF-κB signaling pathways after the activation of two NEMO ubiquitin binding-dependent receptors, TNFR and IL-1βR and in CD40-dependent NF-κB pathway. We report the first human NEMO mutations responsible for X-linked EDA-ID found to affect the polyubiquitin binding of NEMO rather than its expression and folding.
Introduction
Nuclear factor-kappa B (NF-κB) essential modulator (NEMO) is a regulatory subunit of the inhibitor of NF-κB (IκB) kinase (IKK) 1 . NEMO is a scaffold protein essential for the formation of the IKK protein complex catalyzing the phosphorylation of IκBs. In resting cells, NF-κB is sequestered in the cytoplasm through physical interaction with IκBs (IκBα, IκBβ and IκBε). Following stimulation of the cell with diverse molecules, such as proinflammatory cytokines (TNF-α, IL-1β), endotoxins (LPS) or CD40L, the canonical NF-κB signaling pathway is activated 1 . The phosphorylation of IκB leads to its dissociation from NF-κB, resulting in its ubiquitination and degradation in the proteasome. The released NF-κB dimers (p50, p52, c-rel, p65 (also called relA), and Rel-B) are translocated to the nucleus, where they induce the transcription of various target genes encoding proinflammatory molecules, in particular 2 . It has recently been shown that the NEMO protein consists essentially of a series of coiled-coil domains: CC1 in the N-terminal segment, HLX2 in the middle segment and the CC2-LZ regulatory domain in the C-terminal segment. NEMO also has a zinc finger domain (ZF) at its C-terminal end 3 . The function of NEMO depends on its dimerization and its ability to interact with linear or K63-linked polyubiquitin chains [4] [5] [6] [7] . This function requires the CC2-LZ domain, which is involved in NEMO dimerization and contains a ubiquitin-binding site called NOA/UBAN/NUB, and the ZF domain, which bears a second ubiquitin-binding site 8, 9 .
Diverse mutations of NEMO are responsible for various rare X-linked diseases.
Amorphic NEMO mutations leading to a lack of NEMO-dependent NF-κB activation are associated with X-linked dominant incontinentia pigmenti (XD-IP) in females 10 and in utero lethality in males 10, 11 . Hypomorphic NEMO mutations leading to the impairment of NF-κB signaling, but not its abolition, are associated with the syndrome of X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency (XR-EDA-ID) in males [11] [12] [13] [14] [15] [16] [17] [18] [19] . The developmental features of EDA-ID include a typical facies (frontal bossing, saddle nose),
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From aberrant development of skin appendages, such as hair and teeth, and dry skin.
Immunodeficiency results in susceptibility to a wide range of pathogens (pyogenic bacteria, mycobacteria and viruses, in particular) 15, 17, 20 . The extent and severity of the ectodermal phenotype define several different clinical diseases: EDA-ID with osteopetrosis and/or lymphedema (XR-EDA-ID-OL), classical XR-EDA-ID, XR with mild-EDA-ID (e.g. conical incisors only) and ID without EDA 16, [21] [22] [23] A tremendous diversity of immunological receptors signal via NEMO and NF-κB, each potentially contributing to the immunodeficiency of patients with XR-EDA-ID, depending on the specific NEMO mutation. Impaired cellular responses to TNF-α, resulting in a lack of inflammatory cytokine production, are found in at least 80% of patients 24, 25 . About half the patients display defective responses to IL-1β and at least some TLRs. However, most NF-κB-dependent immunological pathways have yet to be tested in patients with XR-EDA-ID. In routine immunological examinations, some patients present various Ig production defects. Some patients present a deficiency in B-cell switching in response to CD40 activation [11] [12] [13] 26 . Interestingly, most, if not all patients lack polysaccharide-specific antibodies, despite infection with and/or vaccination against encapsulated bacteria.
Allohemagglutinin levels are also typically low in these patients. Only a few of the links between NEMO genotype, cellular phenotype and clinical phenotype have been deciphered, such as the lack of EDA-R signaling and the developmental phenotype of EDA 27 , the lack of CD40-dependent induction of IL-12 and mycobacterial disease 20 , and the lack of CD40dependent B-cell switching and hyper IgM syndrome 26 .
The mechanisms by which some mutations affect the structural and functional integrity of NEMO have been more thoroughly investigated. Mutations in exon 1B or 5' untranslated region, result in lower levels of NEMO mRNA and much lower levels of protein 23 , with a clinical phenotype of recurrent sinopulmonary infections and For personal use only. on August 31, 2017. by guest www.bloodjournal.org From dysgammaglobulinemia without EDA 23 . The EDA-ID-associated A288G mutation of NEMO, affecting the CC2 domain, has no effect on protein expression but destabilizes NEMO oligomers (dimers and higher-order oligomers), thereby altering assembly of the IKK complex, and impairing the canonical activation of NF-κB 28 . The ID-associated 110_111insC mutation of NEMO creates a premature translation termination codon in codon position 49 16 .
A methionine codon downstream from the premature stop codon allows the reinitiation of translation. The production of a small amount of residual NH 2 -truncated NEMO results in a phenotype of ID without EDA. The C417F mutation affecting the zinc-finger (ZF) domain of NEMO is responsible for EDA-ID 11, 12 . The production of the C417F protein has not been investigated, but the structures of NEMO ZF and its C417F mutant were recently determined by NMR 3 . The C417F substitution modifies the structure of the C-terminal end of the ZF αhelix and decreases stability, leading to a defect in NF-κB activation. Another substitution, C417R, does not affect the expression of the NEMO protein but impairs c-Rel activation in response to CD40 ligation 29 . The EDA-ID-OL-associated X420W allele includes a new translation termination codon and encodes a protein 27 amino acids longer than the wild-type protein 30 , the expression of which is impaired. Two other mutations affecting the LZ domain of NEMO, E315A and R319Q, disrupt the formation of the salt bridge normally formed between residues E315 and R319 20 , without affecting NEMO protein production 20, 31 . The folding defect of the E315A mutant is responsible for the defect in binding to ubiquitin chains 32 . Thus, some previously characterized NEMO mutations interfere simply with the levels of protein expression, and other, are associated with impairment of the folding and stability of NEMO domains, in some cases, leading to an impairment of NEMO production.
We describe here the structural and functional characterization of the D311N and D311G mutations, which affect the NOA ubiquitin-binding site of NEMO and mediate their 
Patient, materials and methods

Case report
The patient (P) is a boy born in 1992 to non consanguineous parents originating from and living in the French West Indies ( Figure 1A A biopsy revealed the presence of an intracellular mycobacterial infection and the patient was treated with clarithromycin, rifabutin, ethambutol and moxifloxacin for two months, followed by clarithromycin and rifabutin for five months. He presented a new episode of polyarthritis and was prescribed rifabutin, ethambuthol and moxifloxacin for five months, with a partial response. The patient is now 19 years old and presents a fluctuating lesion of the cheek caused by Mycobacterium abcessum. He sweats normally and has all his adult teeth except the maxillary lateral incisors and the first upper premolars on the right. The agenesis of these teeth was confirmed by mandibular X ray, but went unrecognized for some time ( Figure 1B) .
The mother and sister of the patient present no immunodeficiency or IP. Informed consent was obtained from all family members and the study was approved by the Necker IRBs.
MDDC stimulation
Monocyte-derived dendritic cells (MDDC) were obtained from PBMCs. They were incubated for 2 to 3 h in RPMI 1640 supplemented with 10% heat-inactivated pooled FBS (GIBCO), referred to as complete RPMI 1640 medium, as previously reported 20 
Culture and stimulation of cell lines
B lymphocytes were immortalized with Epstein-Barr virus (EBV-B cells) and cultured in complete RPMI 1640 medium. We stimulated 10 6 EBV-B cells with phorbol 12, 13dibutyrate (PDBu 10 -7 M, Sigma-Aldrich) in 24-well plates, for 24 hours, at 37°C, under an atmosphere containing 5% CO 2 . The supernatants were then recovered.
Immunoblotting and DNA-binding activity
For electrophoretic mobility shift assay (EMSA), nuclear extracts were prepared from EBV-B cells incubated with or without 100 ng/ml of soluble MegaCD40L TM for 20 and 40 min and cytosolic extracts for 20, 40, 60 and 120 min.
Pull-down analysis
We analyzed the interaction between His-CC2-LZ (WT, D311N and D311G) and K63-linked or linear tetra-ubiquitin, by carrying out pull-down experiments with NI-NTA magnetic agarose beads (Qiagen). CC2-LZ (8 μM) was incubated with various concentrations of K63- For personal use only. on August 31, 2017. by guest www.bloodjournal.org From
Results
A novel missense germline mutation in NEMO with no impact on protein expression
We studied a boy with recurrent infections, including mycobacterial diseases in particular ( Figure 1A ). This patient has conical incisors and agenesis of the lateral incisors and the upper right first premolar, suggesting a mild form of EDA-ID ( Figure 1B ). Molecular genetic analysis revealed a hemizygous nucleotide substitution at position 932 (A>G) ( Figure 1C ) in exon 8 of NEMO, leading to the substitution of asparagine by glycine at residue 311 (designated D311G). This mutation was detected in cDNA from EBV-B cells and SV-40 transformed fibroblasts from the patient (P), indicating that it was a mutation in NEMO itself (and not its pseudogene). This mutation was not found in any of 1,300 chromosomes from 52 ethnic groups in the HGDP-CEPH database, and it was therefore not an irrelevant polymorphism. The mutation in P was inherited from his mother ( Figure 1A ). We previously reported another missense mutation affecting the same residue, D311N, and conferring a typical clinical phenotype of EDA associated with multiple and recurrent infectious diseases (XR-EDA-ID) 12 (supplemental data). However, the impact of the D311N mutant protein on the NF-κB pathway was not investigated by functional characterization in human cells. The D311 residue of NEMO is conserved in the 33 species in which the NEMO gene has been sequenced to date. This residue is located in the CC2-LZ domain ( Figure S1 ). We investigated the impact of these mutations on protein levels, by carrying out western blotting on cell lines derived from the patient's cells and from the cells of different published patients with NEMO deficiency. We found that the D311G-NEMO mutant protein was produced in the patient's monocytes and granulocytes, in similar amounts to the wild-type NEMO protein in a healthy control ( Figure 1D ). We also analyzed NEMO production in cell lines from patients carrying the D311G or D311N allele. The amounts of NEMO protein generated from the D311G and D311N mutant alleles were similar to the amounts of protein generated from the wild-type Figure S2 ). NEMO protein production was also normal in SV40-transformed fibroblasts carrying the D311G allele ( Figure 1D , Figure S2 ). SV40transformed fibroblasts carrying the D311N allele were not available. Western blotting showed the D311G protein to be produced in normal amounts in fresh cells from the patient and cell lines, including hematopoietic and non hematopoietic cells. We evaluated production of the D311G and D311N mutant NEMO proteins, by transiently transfecting SV40transformed fibroblasts from a XD-IP NEMO patient with WT, D311G and D311N vectors.
Similar amounts of protein were detected for the D311G and D311N mutant proteins and for the wild-type NEMO protein ( Figure 1E ). Thus, these two mutations do not affect the amount of protein produced.
Folding and dimeric stability of the WT and mutant CC2-LZ domains bearing D311N and D311G mutations
We recently showed that most disease-associated mutations affecting the CC2-LZ domain impair polyubiquitin binding indirectly, by disturbing the folding and stability of the CC2-LZ dimer 33 . Despite the demonstration of a lack of polyubiquitin binding in four studies of the D311N mutant protein, no rigorous study has yet been performed to determine whether the D311N mutation also affects the folding of the CC2-LZ ubiquitin-binding domain of NEMO 32, [34] [35] [36] . In addition to investigating the effects of the new D311G mutation, we also studied the aspartate to asparagine substitution at position 311 within the NOA/UBAN ubiquitin-binding site of CC2-LZ domain, by generating and purifying fragments of NEMO (CC2-LZ 258-344 domain) bearing this substitution ( Figure S3 ). Sedimentation equilibrium (SE), sedimentation velocity (SV) and dynamic light scattering (DLS) were used for the complete characterization of CC2-LZ 258-344 WT and mutant oligomers. Neither D311N nor D311G affects the oligomeric status of the CC2-LZ domain, as both mutants formed dimers with For personal use only. on August 31, 2017. by guest www.bloodjournal.org From dimerization constants similar to those of the WT (Table 1) . Furthermore, SV data confirmed that D311N and D311G behaved as homogeneous elongated dimers with a sedimentation coefficient of 1.4 ± 0.1 S (S 20,w = 1.8 S) and a high frictional coefficient of 2.4 ± 0.2. No significant aggregates or higher order oligomers were observed, as shown by SV ( Figure S4) and DLS (data not shown). We then carried out temperature-induced denaturation of the dimer, followed by CD, to determine the thermal stability of the mutants (Figure 2A-B ).
Consistent with previous data, thermal denaturation showed a complete two-state transition, reflecting the dissociation of native dimers into unfolded monomers 33 . The melting curves for D311N and D311G gave melting temperatures (Tm) of 36 ± 0.5°C and 34 ± 0.5°C, respectively, similar to that for the WT (Tm =35 ± 0.5°C). Cooperativities (n) were slightly lower for D311N (7.6) and D311G (7.3) than for the WT (8.6). However, this decrease may be due to a slight difference in the enthalpy (∆H Tm ) and heat capacity values (∆Cp) of dimer denaturation, although these differences were not statistically significant. The far-UV spectra of the two mutants were similar to that of the WT (inset, Figure 2A ) and the deconvolution of CD spectra gave similar, high α-helix contents, indicating an absence of effect of the D311N and D311G substitutions on the dimeric coiled-coil structure. Thus, the D311N and D311G mutations do not affect the folding and dimeric stability of the CC2-LZ domain of NEMO.
The D311N and D311G substitutions disrupt monoubiquitin, K63-linked and linear poly-ubiquitin binding
We next investigated the effects of mutation on polyubiquitin binding. We performed pulldown experiments to assess the ability of the WT and mutant His-tagged CC2-LZs to bind K63-linked and linear tetraubiquitin chains. Unlike previous studies 32 , we compared the interactions of oligomers with four ubiquitins, which have higher affinity than di-ubiquitin chains 5, 33 . Note also that pull-down experiments were carried out in a dose-dependent manner, with His-tag versions of CC2-LZ, but not with GST-tagged proteins 5, [34] [35] [36] , as it has recently been shown that the dimeric GST moiety can artificially influence polyubiquitin binding properties 37 . The D311N substitution decreased the affinities of the protein for K63-linked and linear tetra-ubiquitin chains, by factors of 14 and 15.6, respectively ( Figure 3 and Table   2 ). A similar decrease was observed for the novel D311G mutant protein, as its affinities for K63-linked and linear tetra-ubiquitin chains were lower than those of the WT, by factors of 28 and 32, respectively. The affinity of CC2-LZ for monoubiquitin is too low for easy detection of the complex in a pull-down assay. We therefore used a more sensitive fluorescence assay based on the F312W mutant 33 . This mutant has a single tryptophan residue in the ubiquitinbinding site that can be used as a fluorescent probe for monitoring monoubiquitin binding under equilibrium conditions. The F312W mutant has a dimeric stability similar to that of WT, as shown by SV, SE and thermal denaturation followed by CD (not shown), and the corresponding full-length NEMO mutant fully rescues the TNF-α-induced NF-κB activation observed in NEMO-deficient T lymphocytes 7 . We purified F312W/D311N and F312W/D311G mutant proteins for the quantification of monoubiquitin binding by fluorescence ( Figure S3 ). Moreover, the binding constants of the F312W/D311N and F312W/D311G mutant proteins were lower than that of F312W, by factors of 2.9 and 4.6, respectively, indicating that both mutations also alter monoubiquitin binding ( Figure 3B ).
Impact of the NEMO D311G allele on the cellular response to TNF-α and IL-1β
Many human mutations in the NEMO gene, conferring different clinical and cellular phenotypes in humans, have been reported. Neither of these two mutations has been characterized in cells from patients. We assessed the impact of the NEMO D311G mutation on the NF-κB pathway, by studying IκBα degradation by Western blot. As previously shown 30 , IκBα degradation was impaired in fibroblasts from a patient with XR-EDA-ID-OL, For personal use only. on August 31, 2017. by guest www.bloodjournal.org From whereas it was normal in fibroblasts from a patient with XR-MSMD. The degradation of IκBα in response to TNF-α stimulation was impaired in fibroblasts from the patient carrying the D311G NEMO mutation, as shown by comparison with cells from a healthy control ( Figure 4A ). No such clear phenotype was observed in response to IL-1β activation ( Figure   4A , Figure S5A ). We also assessed nuclear NF-κB p50/p65 complex DNA-binding activity by EMSA. SV40-transformed fibroblasts from the NEMO D311G patient displayed weaker NF-κB-binding activity than cells from a healthy control stimulated with TNF-α or IL-1β ( Figure 4B and Figure S5B, S5C) . These data suggest that the NEMO D311G allele is intrinsically deleterious. NEMO mutations in patients with EDA-ID are usually associated with impairment of the canonical activation of NF-κB [15] [16] [17] . We therefore evaluated cellular responses to TNF-α, in terms of IL-10 induction, in whole blood. Low, but detectable levels of IL-10 were found in whole blood from the patient carrying the D311G allele, as for most previously reported patients bearing hypomorphic NEMO mutations ( Figure 4C ). We then stimulated SV40-transformed fibroblasts from a healthy control, patients with XD-IP, XR-EDA-ID-OL, and XR-MSMD, and the patient with the D311G allele (P), with TNF-α and IL-1β. We observed an impairment of IL-6 and IL-8 production by cells from P, following stimulation with TNF-α ( Figure 4D , and Figure S6A ) and IL-1β ( Figure 4D and Figure S6B ), as observed with fibroblasts from the XR-EDA-ID-OL patient, but not with those from the XR-MSMD patient, which secreted IL-6 and IL-8 normally after activation with TNF-α and IL-1β 20 .
Impact of the NEMO D311G allele on the IL-12/IFN-γ pathway
Most patients with NEMO mutations are susceptible to mycobacterial infections, and those carrying the R319Q and E315A mutations seem to be specifically susceptible to mycobacteria (XR-MSMD) 12, 16, 20 . The mechanism underlying this susceptibility involves the impairment of For personal use only. on August 31, 2017. by guest www.bloodjournal.org From CD40-dependent IL-12 production 20 . The patients carrying the D311G and D311N mutations had mycobacterial diseases. We thus evaluated the impact of the NEMO D311G mutation on the IL-12/IFN-γ pathway. Unfortunately, whole blood and fresh leukocytes could not be obtained from the patient with the D311N mutation, who died in 2000. We activated whole blood from the other patient (P), with the D311G mutation, with live BCG alone, or with IL-12 or IFN-γ. The BCG plus IL-12 response was normal in terms of IFN-γ production ( Figure   5A ). IL-12-p40 production was also similar to that of the positive control following stimulation with BCG plus IFN-γ ( Figure 5B ). This immunological result, obtained with fresh blood cells, is consistent with those obtained for XR-MSMD patients with NEMO mutations 20 , demonstrating the maintenance of the microbe-dependent, T cell-and CD40independent pathway of IL-12 production. We also investigated the impact of the D311G and D311N mutations on IL-12 production by EBV-B cells stimulated with a phorbol ester (PDBu). EBV-B cells from healthy controls (n=9), patients with IL-12B deficiency (n=2), a patient with complete CD40 deficiency, patients with XR-EDA-ID (n=5), patients with the D311N and D311G mutations (n=2), and XR-MSMD NEMO patients (n=2) were tested.
EBV-B cells bearing the D311N and D311G mutations displayed impaired IL-12p40
production in response to PDBu stimulation ( Figure 5C and Figure S7A ). This defect is observed in some EDA-ID patients and has already been reported for the first XR-MSMD patients described 20 . TNF-α production in response to PDBu was studied as a control and found to be normal in D311N and D311G cells ( Figure S7B ).
Impact of the NEMO D311G allele on the CD40-dependent NF-κB pathway
In previous studies with XR-MSMD patients, we reported an NF-κB defect affecting NF-κB/c-Rel binding activity in response to CD40 stimulation 20 . We investigated the CD40triggered NF-κB pathway, by generating EBV-B cell lines from the frozen PBMCs of the whereas the XR-EDA-ID-OL NEMO patient did not ( Figure 6A ). However, NF-κB complex DNA-binding activity involving p50, p65, c-Rel and Rel-B subunit ( Figure 6B and Figure   S8 ), measured by EMSA, was much weaker for the NEMO D311G patient, an XR-EDA-ID-OL NEMO patient (X420W), an XR-MSMD NEMO patient (R319Q), and the D311N NEMO patient than for the healthy control (C + ). No induction was observed in cells from a patient with complete CD40 deficiency ( Figure 6B and Figure S8 ). XR-MSMD NEMO patients display impaired IL-12 production by MDDCs 20 . We therefore assessed the response to CD40 pathway activation, using MDDCs from eight healthy controls, a patient with a complete CD40 deficiency, an XR-MSMD NEMO patient (R319Q) and patients with the D311N and D311G NEMO mutations. MDDCs generated from frozen PBMCs were activated by incubation for 24 hours with trimeric soluble CD40L. Impaired IL-12p40 production was observed in MDDCs from both D311N and D311G NEMO patients, as in XR-MSMD NEMO patients and the CD40 -/patient ( Figure 6C ). IL-6 production in response to stimulation with LPS plus IL-1β was studied as a control and was normal in D311N and D311G cells ( Figure   S9 ). These finding are consistent with a defect of the CD40-NEMO-NF-κB signaling pathway, and provide an explanation for the susceptibility to mycobacterial diseases observed in this patient. The mechanism by which some NEMO mutations impair the PDBu-dependent induction of IL-12 in EBV-B cells whereas others do not is unknown, but seems to be correlated with NEMO-dependent impairment of the CD40-dependent induction of IL-12 in
MDDCs.
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Discussion
Previously reported NEMO mutations have been shown to impair the production and/or folding of the protein 3, 12, 16, 20, 28, 30 .We report here that the XR-EDA-ID-causing NEMO mutations D311G and D311N prevent the binding of NEMO to ubiquitin, but have no effect on its production and folding. In this study, we investigated mutant proteins in cells from patients and cell lines derived from patients' cells. By contrast to other studies based on transfected cells or animal models, the protein levels demonstrated here are representative of reality. This is the first study in which folding has been rigorously investigated for these two mutant proteins, leading to the conclusion that NEMO folding is perfectly conserved in both cases. The D311G and D311N mutations selectively affect the binding of the protein to ubiquitin. These mutations have no effect on the stability and dimerization of the CC2-LZ NEMO domain or the thermal stability of NEMO ZF, unlike the previously reported mutations 3, 28 . Residue D311 is located in the NOA ubiquitin-binding site of NEMO. We showed that the mutation of this residue resulted in a strong defect in binding to linear and K63-linked polyubiquitin chains. These findings are consistent with those of previous studies on cell lines for D311N 5, 32, 34, 36 . However, this is the first ever analysis of the D311G mutant protein. We provide here the first report of human patients with immunodeficiency and specific impairment of NEMO binding to polyubiquitin. These findings support the hypothesis that the binding of human NEMO to linear or K63-linked polyubiquitin chains is critical for NF-κB signaling. Furthermore, they demonstrate that the production of normal amounts of NEMO is not sufficient to rule out a diagnosis of NEMO deficiency in a patient with EDA-ID or in a patient with a coding mutation in NEMO, or both.
Consistent with previous studies 5, 7 , we observed that the NEMO WT CC2-LZ had a higher affinity for the Lys63-linked tetraubiquitin chain than for K63-diubiquitin. Indeed, a K D value of 4 µM was found for K63-tetraubiquitin chains whereas those reported for K63-diubiquitin For personal use only. on August 31, 2017. by guest www.bloodjournal.org From were 131 µM and 12 µM in isothermal titration calorimetry and biolayer interferometry, respectively 32, 38 . This gain of affinity was not observed with linear chains, for which similar binding constants, of around 1-2 µM were obtained for dimeric, tetrameric and nonameric polyubiquitin chains 5, 7, 32 . Therefore, the linkage specificity between linear and K63 chains is markedly lower when longer oligomers of ubiquitin (>2) are considered. One possible reason for this is the distinct rotational flexibility and spacing of ubiquitin units that result from a particular linkage. A K63-linked tetraubiquitin chain, unlike diubiquitin, may wrap around the dimeric NEMO NOA/UBAN and simultaneously bind, in a perpendicular fashion, the two distal ubiquitin-binding sites 5, 32 . By contrast, a linear tetraubiquitin chain may bind in a parallel fashion similar to that of a linear diubiquitin chain ( Figure 7C ), such that two adjacent ubiquitin moieties can bind both proximal and distal ubiquitin binding sites on the CC2-LZ dimer 5 .
No asparagine substitution other than D311N has been reported in NEMO.
Interestingly, other glycine substitutions in NEMO have different molecular impacts, despite the similarity of their clinical impact, resulting in EDA-ID disease. Indeed, the EDA-IDrelated A288G mutation, which affects the dimerization core of the CC2 region of NEMO (outside the NOA ubiquitin-binding site; Figure 7A -B), alters NEMO function by disrupting NEMO dimerization and, probably, higher order oligomerization as well. By contrast, the D311G substitution on one side of the dimerization core of the NOA ubiquitin-binding site ( Figure 7C ) severely impairs polyubiquitin binding without disturbing the dimeric coiled coil structure. Nevertheless, as dimerization of the NEMO CC2-LZ domain is absolutely required for efficient binding to K63-linked and linear chains 33 , both glycine substitutions, at positions 288 and 311, may lead to defective polyubiquitin binding, accounting for the similarity of the EDA-ID diseases they cause.
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From It is also interesting to speculate how mutations affecting the NEMO CC2-LZ domain can lead to clinical diseases as radically different as a narrow predisposition to mycobacterial diseases (XR-MSMD, mutations E315A, and R319Q) 20 and immunodeficiency with mild or classical signs of EDA (mutations A288G and 811_28del) 15, 28 . Recent pull-down assay studies have reported that the R319Q and E315A mutations associated with MSMD result in a milder defect in ubiquitin binding than the D311N mutation associated with EDA-ID 32 . The
D311G mutation is as deleterious as D311N in human cells (fibroblasts and EBV-B cells) and
has a more damaging effect on polyubiquitin binding than the mutations associated with pure MSMD. These differences may account for the normal NF-κB activation observed after activation with TNF-α or IL-1β in the fibroblasts of MSMD patients 20 and the significantly lower levels of NF-κB activation in fibroblasts derived from the patient with the D311G mutation associated with an EDA-like ID-associated disease. Interesting, the impact of the D311G and D311N mutations differs in different cells (fibroblasts, EBV-B cells, dendritic cells), the subunits associated in NEMO (different IκB and NF-κB subunits) and the level of activation of the pathway (degradation of different IkBs, DNA binding activity, production of cytokines), suggesting that there is a specific requirement for NEMO. Thus, detailed NF-κBdependent immunological pathways should be investigated in these patients. In any event, impaired ubiquitin binding is clearly the molecular mechanism of disease in patients with the D311G and D311N mutations of NEMO, and this mechanism may contribute to disease in patients with other mutations with and without effects on protein stability 18, 19 . The binding of human NEMO to ubiquitin is therefore essential for NF-κB activation in vivo. Furthermore, our findings demonstrate that normal levels of NEMO production and normal folding of this molecule should not be considered sufficient to exclude a diagnosis of NEMO deficiency in patients with XR-EDA-ID and/or NEMO mutations. Mean molecular masses (Da) and monomer-dimer equilibrium constants (Κ D ) were determined at 10°C, with an initial protein concentration of 15 μM, as described in the methods. The theoretical molecular masses of the dimers are indicated for each construct.
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Figure Legends
